AstraZeneca razes R&D facilities in Delaware

AstraZeneca's ($AZN) former R&D operations in Delaware, abandoned years ago in the pharma giant's ongoing restructuring and downsizing, are being razed. The pharma giant says it is leveling three buildings that once comprised 450,000 square feet of research space. "Because we no longer carry out discovery or other laboratory research activities at this location, we are removing the buildings that were previously home to that R&D work, which has relocated to our other sites across the globe," the company said in a statement released to The News Journal. Story